Addiction. Mental and behavioural disorders due to psychoactive substance use
Conditions
Interventions
Intervention 1: Intervention group: week 5 mg and 30 mg doses of methadone little saffron in the beginning of the study, the patient is given a survey carried out for 8 weeks the patient's symptom. In
Treatment - Drugs
Placebo
Intervention group: week 5 mg and 30 mg doses of methadone little saffron in the beginning of the study, the patient is given a survey carried out for 8 weeks the patient's symptom
Control: instead of saffron capsules to patients given placebo capsules self
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: in methadone maintenance phase stability; any one underlying disease; Consent to inclusion are injection molded. Exclusion Criteria: have underlying medical condition; Lack of personal satisfaction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rinoreh. Timepoint: Every week untill two months. Method of measurement: Self-reported.;Miyalgia. Timepoint: Every week untill two months. Method of measurement: Self-reported.;Loss of appetite. Timepoint: Every week untill two months. Method of measurement: Self-reported.;Temptation. Timepoint: Every week untill two months. Method of measurement: Self-reported.;Diarriah. Timepoint: Every week untill two months. Method of measurement: Self-reported.;Anxiety. Timepoint: Every week untill two months. Method of measurement: Self-reported. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact??Atefeh Asadi
Medical Director of the lab
Outcome results
None listed